Portfolio company
Alamar Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Quanterix
This company develops ultra-sensitive biomarker detection platforms and assay kits for pharmaceutical companies, academic institutions, and clinical laboratories.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
